The pharmacokinetic profiles of formoterol and beclometasone-@-monopropionate ( B@MP ; active metabolite of BDP ) were evaluated over @ h from two independent studies comprising children ( @-@yrs , n = @ ) , adolescents ( @-@ yrs , n = @ ) and adults ( @ yrs , n = @ ) receiving a single , fixed dose of BDP/formoterol ( children : @ g/@ g , adolescents and adults : @ g/@ g ) via DPI .